コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 0.14; 95% CI, 0.07-0.27; reference category, obstetrics).
2 ibuted to increasing the usefulness of US in obstetrics.
3 tpartum recovery is an underexplored area of obstetrics.
4 ess a rounder inlet, which is beneficial for obstetrics.
5 de a summary of recent guidance on sepsis in obstetrics.
6 make it potentially very suitable for use in obstetrics.
7 erent hospitals and specialties: 18 (29%) in obstetrics, 16 (26%) in medicine, and 11 (18%) in each o
8 f International Federation of Gynecology and Obstetrics 2009 stage IA2 or IB1 squamous cell carcinoma
9 the most significant problem in contemporary obstetrics accounting for 5-18% of worldwide deliveries.
10 ess likely to report race and ethnicity than obstetrics (adjusted odds ratio [aOR], 0.54; 95% CI, 0.3
11 ents a significant challenge in reproductive obstetrics, affecting approximately 5% of couples global
12 m my perspective as a physician in high-risk obstetrics and 2019 American Diabetes Association Pathwa
15 adult patients and relatives who visited the Obstetrics and Gynaecology and General Surgery Clinics o
16 ent of Anaesthesia, Surgery, Otolaryngology, Obstetrics and Gynaecology and Ophthalmology) and geogra
17 scrub nurses were randomly selected from the Obstetrics and Gynaecology Department of a teaching hosp
18 e at the respective health facilities in the Obstetrics and Gynaecology Department of Lagos State Uni
19 tedly healthy term new-born infants from the Obstetrics and Gynaecology ward at Hospital Kuala Lumpur
21 White participants) who practiced in general obstetrics and gynecology (39 [72%]), maternal-fetal med
22 surgery (AOR, 2.05 [95% CI, 1.62-2.58]), and obstetrics and gynecology (AOR, 1.64 [95% CI, 1.24-2.15]
23 (n=3 each); surgical centers, fertility, and obstetrics and gynecology (n=2 each); and anesthesia, ho
28 affect the training of approximately 44% of obstetrics and gynecology (OBGYN) residents in the US.
29 y examines racial and ethnic diversity among obstetrics and gynecology (OBGYN), surgical, and nonsurg
32 nternal medicine [IM], family medicine [FM], obstetrics and gynecology [OBGYN]) and 3 largest surgica
34 imary specialty germane to the substudy (ie, obstetrics and gynecology for substudies 1 and 3 and pul
35 e recommendations of the American College of Obstetrics and Gynecology for women treated with tamoxif
36 or survival benefit, the American College of Obstetrics and Gynecology has recommendations for referr
38 ctive study carried out in the Department of Obstetrics and Gynecology Ramon y Cajal University Hospi
39 blished CE-OOC may become a powerful tool in obstetrics and gynecology research such as in studying c
41 obstetrics and gynecology residents and 293 obstetrics and gynecology residency program directors in
42 was prevalence of payer-based segregation in obstetrics and gynecology residency programs in the US a
43 rs, payer-based segregation was prevalent in obstetrics and gynecology residency programs, particular
44 This national survey study included all 6060 obstetrics and gynecology residents and 293 obstetrics a
45 ndent demographics reflected demographics of obstetrics and gynecology residents nationally in terms
46 03 patients with International Federation of Obstetrics and Gynecology stage III (n = 172) or IV (n =
48 ams (internal medicine, family medicine, and obstetrics and gynecology) and patient survey data were
49 tments were negative (anesthesiology, -1.1%; obstetrics and gynecology, -0.5%; radiology, -0.4%; and
50 l medicine and subspecialties, 2 (6.9%) from obstetrics and gynecology, 3 (10.3%) family medicine, 2
51 GME in specialties such as general surgery, obstetrics and gynecology, and emergency medicine has in
52 specialties of psychiatry, child psychiatry, obstetrics and gynecology, and family and general practi
54 armacy, telephone calls to the department of obstetrics and gynecology, and prenatal visits with phys
56 , endocrinology, nephrology, psychiatry, and obstetrics and gynecology, but also from recognized expe
57 ls in general medicine, pediatrics, surgery, obstetrics and gynecology, cancer, cardiovascular diseas
58 ans from family medicine, internal medicine, obstetrics and gynecology, cardiology, pulmonary, and on
59 , even female-dominated specialties, such as obstetrics and gynecology, have substantial inequity in
61 control group, born at the 1st Department of Obstetrics and Gynecology, Medical University of Warsaw,
62 ry and 5 surgical specialties (neurosurgery, obstetrics and gynecology, ophthalmology, orthopedics, a
63 geons across multiple specialties, including obstetrics and gynecology, otolaryngology, and orthopedi
65 general and plastic surgery, otolaryngology, obstetrics and gynecology, physical medicine, hematology
66 ialties (internal medicine, family practice, obstetrics and gynecology, surgery, pediatrics, and psyc
72 he Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intr
79 sciplinary collaboration between hematology, obstetrics, and anesthesia and shared decision-making wi
80 Association of Professors of Gynecology and Obstetrics, and Council on Resident Education in Obstetr
81 cine, hematology, oncology, transplantation, obstetrics, and immunology, among other areas, are neede
82 es in the management of sickle cell disease, obstetrics, and neonatal medicine, pregnancies complicat
84 of pregnancy complications: a mouse model of obstetrics antiphospholipid syndrome (APS) and a mouse m
85 es were more commonly accepted, particularly obstetrics (aOR, 5.28; 95% CI, 4.17-6.70), STEMI (aOR, 3
86 tives of national pediatric, gynecology, and obstetrics associations, national immunization technical
87 commercial equipment, that its usefulness in obstetrics began to be realized fully by radiologists an
88 or at a tertian-care center with a high-risk obstetrics/cardiology clinic and 66 individually selecte
89 (International Federation of Gynaecology and Obstetrics) classification for the staging of endometria
91 uch methods are of great significance to the obstetrics community because of their potential use as c
92 re operative blood loss is expected (surgery/obstetrics) compared with those where blood loss is not
94 nd transplants; COVID-19; ICU stays; sepsis; obstetrics; diabetes; and coagulopathies like hemophilia
95 ve scientific statements from cardiology and obstetrics experts guide the treatment of cardio-obstetr
96 rasound Doppler, Cardiac, Heart, Congenital, Obstetrics, Fetus Supplemental material is available for
97 International Federation of Gynaecology and Obstetrics (FIGO) 2009 stage I, endometrioid grade 3 can
98 9 International Federation of Gynecology and Obstetrics (FIGO) criteria (91.7%), that had squamous-ce
100 h International Federation of Gynecology and Obstetrics (FIGO) high-risk stage I-IV epithelial ovaria
101 International Federation of Gynaecology and Obstetrics (FIGO) risk score of 5 or 6 usually receive n
102 d International Federation of Gynecology and Obstetrics (FIGO) score was 0-4 in 33.3%, 5-6 in 46.7%,
103 , International Federation of Gynecology and Obstetrics (FIGO) stage distribution, and methodologic q
104 e International Federation of Gynecology and Obstetrics (FIGO) stage I (including borderline), two st
105 [International Federation of Gynecology and Obstetrics (FIGO) stage I/II of non-endometrioid histolo
106 International Federation of Gynaecology and Obstetrics (FIGO) stage IA1 with lymphovascular space in
107 h International Federation of Gynecology and Obstetrics (FIGO) stage IB to IV cervical cancer between
108 e International Federation of Gynecology and Obstetrics (FIGO) stage IB-IVA disease or FIGO stage IVB
109 n International Federation of Gynecology and Obstetrics (FIGO) stage IB3 squamous cell carcinoma of t
110 n International Federation of Gynecology and Obstetrics (FIGO) stage IC-IV epithelial ovarian cancer
111 d International Federation of Gynecology and Obstetrics (FIGO) stage II endometrial cancer: a 12-cm g
112 d International Federation of Gynecology and Obstetrics (FIGO) stage III to IV epithelial ovarian, pr
115 , International Federation of Gynecology and Obstetrics (FIGO) stages IIB through IVA, when lesions a
116 d International Federation of Gynecology and Obstetrics (FIGO) staging system for uterine cancer.
117 International Federation of Gynaecology and Obstetrics (FIGO) staging system was published, aiming t
118 d International Federation of Gynecology and Obstetrics (FIGO; 1988) stage IC-IIA high-grade serous,
119 (International Federation of Gynecology and Obstetrics [FIGO] stage I-IIa, grade 3 or clear cell his
120 (International Federation of Gynecology and Obstetrics [FIGO] stage III), for which the standard of
121 siologists in a variety of circumstances: in obstetrics for labor and emergencies, in trauma for emer
122 Fowler position, widely used in surgery and obstetrics for patient placement, marks a fraction of 19
124 s in haematology, primary care, paediatrics, obstetrics, gastroenterology, cancer, and patient advoca
125 a International Federation of Gynecology and Obstetrics grade 3, uterine serous carcinoma, or carcino
127 tern Med), the Annals of Surgery (Ann Surg), Obstetrics & Gynecology (Obstet Gynecol), and the Journa
130 seeking care in the general medical care and obstetrics-gynecology clinics of an urban public hospita
132 November 2010 among postgraduate trainees in obstetrics-gynecology in 7 LMICs (Argentina, Brazil, Dem
133 Collaborative depression care adapted to obstetrics-gynecology settings had a greater impact on d
134 teen studies looked at general surgery, 6 at obstetrics-gynecology, 2 at urology, and 1 at otolaryngo
135 ar to be inclusive, because family medicine, obstetrics-gynecology, orthopedic surgery, and neurology
136 se exposures, 82% occurred on four services: obstetrics-gynecology, surgery, medicine, and emergency
137 taking internal medicine first compared with obstetrics/gynecology (mean difference, 0.65; 95% CI, 0.
139 ernal medicine, family medicine, pediatrics, obstetrics/gynecology [OB/GYN] and 4 surgical specialtie
140 h-year medical students completing an 8-week obstetrics/gynecology clinical rotation, attendance at c
143 ase in debt (vs no debt), graduates choosing obstetrics/gynecology were less likely to be board certi
144 sistent recommendations varied by specialty (obstetrics/gynecology, 16.4%; internal medicine, 27.5%;
145 ernal medicine, 25.33 [95% CI, 25.07-25.60], obstetrics/gynecology, 24.68 [95% CI, 24.32-25.05], pedi
146 ernal medicine, 73.86 [95% CI, 73.33-74.39], obstetrics/gynecology, 72.36 [95% CI, 71.64-73.04], pedi
147 urology, orthopedic surgery, otolaryngology, obstetrics/gynecology, and ophthalmology clinics of the
148 hould be expanded to include antenatal care, obstetrics/gynecology, and targeted mass vaccination cam
149 l surgery, neurosurgery, orthopedic surgery, obstetrics/gynecology, emergency medicine, and radiology
150 ernal medicine, pediatrics, family practice, obstetrics/gynecology, general surgery, orthopedic surge
151 urgery, vascular surgery, pediatric surgery, obstetrics/gynecology, ophthalmology, and urology (n = 1
157 e International Federation of Gynecology and Obstetrics have produced standardized terminology and a
158 A substantial number of women treated in obstetrics have unrecognized and untreated psychiatric d
159 other-infant pairs were recruited at a large obstetrics hospital in Mexico City, Mexico, randomly ass
162 ssigned to US rotation, (b) the inclusion of obstetrics in US rotation, and (c) the opportunity for h
168 mands a multidisciplinary approach involving obstetrics, maternal-fetal medicine, and various surgica
169 ing, which involved international experts in obstetrics, midwifery, obstetric medicine, paediatrics,
170 6902 of 81 871 women (8.4%) with traditional obstetrics-model care (adjusted relative risks [aRR], 0.
171 with less postpartum ED use than traditional obstetrics-model care among women who had low risk and w
172 e between women with midwifery-model care vs obstetrics-model care, weighting by propensity score-bas
175 , or safety-net service lines (trauma, burn, obstetrics, neonatal intensive, and psychiatric care).
177 cardiovascular risk and ensuring that cardio-obstetrics patients have access to the appropriate care
178 Because Medicare DRGs are unsuitable for obstetrics, pediatrics, and neonatology, some payers pre
179 g, bone marrow transplantation, ethics, law, obstetrics, pediatrics, and the social sciences were inv
182 omized controlled trial was conducted at the obstetrics registration centers of 3 tertiary public hos
183 (International Federation of Gynecology and Obstetrics score >/= 7) gestational trophoblastic neopla
184 rienced hematologist/oncologist, a high-risk obstetrics specialist, a neonatologist, and experienced
185 eptance, considering prioritized conditions (obstetrics, ST-elevation myocardial infarction [STEMI],
188 r International Federation of Gynecology and Obstetrics stage I or II carcinoma of the cervix were re
189 k International Federation of Gynecology and Obstetrics stage I or stage II to IV epithelial ovarian,
191 le and most had Federation of Gynecology and Obstetrics stage IB(1) and squamous cell carcinoma histo
192 h International Federation of Gynecology and Obstetrics stage IB1 cervical carcinoma who underwent at
193 h International Federation of Gynecology and Obstetrics stage IB2-IIb were randomly assigned between
194 h International Federation of Gynecology and Obstetrics stage Ic to IV disease to six cycles of docet
195 d International Federation of Gynecology and Obstetrics stage IC-IIA high-grade serous, clear cell, o
196 d International Federation of Gynecology and Obstetrics stage IC-IV epithelial ovarian cancer were ra
197 d International Federation of Gynecology and Obstetrics stage IC-IV ovarian cancer and an Eastern Coo
198 h International Federation of Gynecology and Obstetrics stage IIB to IV ovarian, fallopian tube, or p
199 (International Federation of Gynecology and Obstetrics stage IIB to IVA or with positive lymph nodes
200 f International Federation of Gynecology and Obstetrics stage III or IV epithelial ovarian cancer, bi
201 h International Federation of Gynecology and Obstetrics stage III or IV tumors received chemotherapy,
202 (International Federation of Gynecology and Obstetrics stage III or IV) who underwent first-line pla
203 h International Federation of Gynecology and Obstetrics stage III to IV ovarian cancer in complete cl
204 h International Federation of Gynecology and Obstetrics stage IV EOC who underwent primary surgery fo
206 , International Federation of Gynecology and Obstetrics stage, tumor grade, pelvic node status, and t
210 l International Federation of Gynecology and Obstetrics stages IB2 (n = 79), IIA (n = 10), IIB (n = 1
211 d International Federation of Gynecology and Obstetrics stages II to IV or relapsed stage I epithelia
214 (International Federation of Gynecology and Obstetrics) stages of EC were included, but patients wit
215 d International Federation of Gynecology and Obstetrics staging of gynecologic malignancies are also
216 8 International Federation of Gynecology and Obstetrics staging system for uterine cervical cancer.
217 e International Federation of Gynecology and Obstetrics staging system's stage, residual disease, his
222 er, the current diagnostic tools in clinical obstetrics, such as Doppler ultrasound measurements of u
224 identified patients evaluated by our cardio-obstetrics team from January 1, 2010, through December 3
226 n counseling by the multidisciplinary cardio-obstetrics team is essential for women with preexistent
228 d-insured pregnant women managed by a cardio-obstetrics team, maternal outcomes were encouraging and
230 h opens new horizons for drug development in obstetrics that could greatly impact preterm birth, whic
232 k-stratification tools are routinely used in obstetrics to assist care teams in assessing and communi
233 Association of Professors of Gynecology and Obstetrics (to clerkship directors), and the Council on
234 vides a blueprint on incorporation of cardio-obstetrics training into cardiovascular disease fellowsh
235 various disciplines (hematology, nephrology, obstetrics, transplantation, rheumatology, and neurology
237 e (median) episiotomy has no place in modern obstetrics; when episiotomy must be performed for obstet